Search results for "prospective"

showing 10 items of 3738 documents

Inhaled isoflurane via the anaesthetic conserving device versus propofol for sedation of invasively ventilated patients in intensive care units in Ge…

2021

Summary Background Previous studies indicate that isoflurane could be useful for the sedation of patients in the intensive care unit (ICU), but prospective studies evaluating isoflurane's efficacy have been small. The aim of this study was to test whether the sedation with isoflurane was non-inferior to sedation with propofol. Methods This phase 3, randomised, controlled, open-label non-inferiority trial evaluated the efficacy and safety of up to 54 h of isoflurane compared with propofol in adults (aged ≥18 years) who were invasively ventilated in ICUs in Germany (21 sites) and Slovenia (three sites). Patients were randomly assigned (1:1) to isoflurane inhalation via the Sedaconda anaesthet…

Pulmonary and Respiratory MedicineAdultSedationPopulationSlovenialaw.inventionlawIntensive careGermanyClinical endpointMedicineHumansHypnotics and SedativesProspective StudieseducationProspective cohort studyPropofolAnestheticseducation.field_of_studyIsofluranebusiness.industryIntensive care unitRespiration ArtificialIntensive Care UnitsIsofluraneAnesthesiamedicine.symptombusinessPropofolmedicine.drugThe Lancet. Respiratory medicine
researchProduct

High-Dose ϵ-Aminocaproic Acid Versus Aprotinin: Antifibrinolytic Efficacy in First-Time Coronary Operations

1998

The antifibrinolytic efficacy of a high-dose regimen of epsilon-aminocaproic acid (epsilon-ACA) was compared with aprotinin in first-time coronary operations.In a prospective, double-blinded, randomized study, 20 patients received high-dose epsilon-ACA (10 g both as a loading and cardiopulmonary bypass priming dose, 2.5 g/h until 4 hours after protamine), and another 20 patients received aprotinin (2 x 10(6) KIU [280 mg] for loading and priming, 0.5 x 10(6) KIU/h [70 mg/h]). Ten untreated patients served as controls.Both agents reduced postoperative levels of thrombin/antithrombin III complexes, D-dimers, fibrin degradation products, free plasma hemoglobin (epsilon-ACA versus aprotinin, p =…

Pulmonary and Respiratory MedicineAntifibrinolyticmedicine.drug_classHematocritHemostaticsFibrinlaw.inventionBlood Transfusion AutologousAprotininThrombinDouble-Blind MethodlawMyocardial RevascularizationmedicineCardiopulmonary bypassHumansBlood TransfusionAprotininProspective StudiesBlood CoagulationCardiopulmonary Bypassbiologymedicine.diagnostic_testbusiness.industryFibrinolysisAntithrombinAntifibrinolytic AgentsHematocritAnesthesiaAminocaproic Acidbiology.proteinSurgeryAminocaproic acidCardiology and Cardiovascular Medicinebusinessmedicine.drugThe Annals of Thoracic Surgery
researchProduct

The amyotrophic lateral sclerosis functional rating scale predicts survival time in amyotrophic lateral sclerosis patients on invasive mechanical ven…

2007

Objective: To determine whether the amyotrophic lateral sclerosis functional rating scale (ALSFRS), which is a validated instrument that assesses the functional status and the disease progression in patients with amyotrophic lateral sclerosis (ALS), predicts hospital length of stay and survival time in ALS patients treated with tracheostomy-intermittent positive-pressure ventilation (TIPPV). Methods: Thirty-three consecutive ALS patients with acute respiratory failure who received therapy with TIPPV were prospectively followed up from their admission to the hospital until death. The association of ALSFRS score at hospital admission with length of hospital stay and survival after TIPPV were …

Pulmonary and Respiratory MedicineArtificial ventilationMalemedicine.medical_specialtymedicine.medical_treatmentCritical Care and Intensive Care MedicineSeverity of Illness Indexlaw.inventionIntermittent Positive-Pressure VentilationlawPredictive Value of TestsInternal medicineSickness Impact ProfileSeverity of illnessmedicineHumansProspective StudiesProspective cohort studyAgedProportional Hazards ModelsMechanical ventilationProportional hazards modelbusiness.industryHazard ratioAmyotrophic Lateral SclerosisLength of StayMiddle AgedPrognosisIntensive care unitSurgeryRespiratory failureAcute DiseaseDisease ProgressionSettore MED/26 - NeurologiaFemaleCardiology and Cardiovascular MedicinebusinessRespiratory InsufficiencyChest
researchProduct

Wirksamkeit und Verträglichkeit von Salmeterol in der Langzeit-therapie bei Patienten mit obstruktiver Atemwegserkrankung

2000

BACKGROUND Salmeterol is a long-acting inhaled beta 2-agonist with a bronchodilating effect lasting over 10 to 12 hours. METHODS A prospective, open, multi-centre study was performed to evaluate the efficacy and safety of inhaled salmeterol (50 micrograms BID) over a mean treatment period of 29 months (range: 4-1145 days) in 634 patients (54% male, age 45 +/- 15 years) with mild to moderate asthma or chronic obstructive pulmonary disease (COPD). Peak expiratory flow rates, rescue use of short acting beta 2-agonists and safety were study objectives. Patients were critically monitored for a possible loss of bronchodilator efficacy of salmeterol during long-term treatment. RESULTS During the f…

Pulmonary and Respiratory MedicineCOPDInhalationmedicine.drug_classbusiness.industryTachyphylaxismedicine.diseaserespiratory tract diseasesBronchodilatorAnesthesiamedicineSalbutamolSalmeterolbusinessProspective cohort studyAdverse effectmedicine.drugPneumologie
researchProduct

FEV1 Predicts Cardiac Status and Outcome in Chronic Heart Failure

2022

Background COPD is an established predictor of clinical outcome in patients with chronic heart failure (HF). However, little evidence is available about the predictive value of FEV1 in chronic HF. Research Question Is pulmonary function related to the progression of chronic HF? Study Design and Methods The MyoVasc study ( ClinicalTrials.gov Identifier: NCT04064450) is a prospective cohort study of HF. Information on pulmonary and cardiac functional and structural status was obtained by body plethysmography and echocardiography. The primary study end point was worsening of HF. Results Overall 2,998 participants (age range, 35-84 years) with available FEV1 data were eligible for analysis. Lin…

Pulmonary and Respiratory MedicineCardiac function curvemedicine.medical_specialtyCOPDEjection fractionbusiness.industryDiastoleCritical Care and Intensive Care Medicinemedicine.diseasePulmonary function testingInternal medicineHeart failureCardiologyMedicineCardiology and Cardiovascular MedicinebusinessHeart failure with preserved ejection fractionProspective cohort studyChest
researchProduct

Effect of High-Frequency Oscillations on Cough Peak Flows Generated by Mechanical In-Exsufflation in Medically Stable Subjects With Amyotrophic Later…

2016

BACKGROUND: Mechanically assisted coughing with mechanical in-exsufflation (MI-E) is recommended for noninvasive management of respiratory secretions in amyotrophic lateral sclerosis (ALS). To improve the effectiveness of the technique, a new device combining MI-E with high-frequency oscillations (HFO) has been developed. This work aimed to assess the effect of HFO on the cough peak flow generated by MI-E in medically stable subjects with ALS. METHODS: This was a prospective study that included subjects with ALS in a medically stable condition. Cough peak flow generated by MI-E was measured in 4 situations: without HFO, with HFO during insufflation, with HFO during exsufflation, and with HF…

Pulmonary and Respiratory MedicineInsufflationMalemedicine.medical_treatmentHigh-Frequency VentilationPeak Expiratory Flow RateCritical Care and Intensive Care Medicine03 medical and health sciencesFEV1/FVC ratio0302 clinical medicineMedicineHumansNew deviceProspective StudiesRespiratory systemAmyotrophic lateral sclerosisAgedbusiness.industryHigh-frequency ventilationAmyotrophic Lateral SclerosisInsufflationGeneral MedicineMiddle Agedmedicine.diseaseTreatment Outcome030228 respiratory systemRespiratory failureCoughAnesthesiaFemaleExsufflationbusiness030217 neurology & neurosurgeryRespiratory care
researchProduct

High Flow Nasal Therapy Use in Patients with Acute Exacerbation of COPD and Bronchiectasis: A Feasibility Study

2020

The efficacy and feasibility of high flow nasal therapy (HFNT) use in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) and bronchiectasis is unknown. We performed a single-center, single-arm prospective observational study in patients with AECOPD, documented bronchiectasis, pH >= 7.35, respiratory rate (RR) >= 26 breaths/minute despite receiving maximal medical treatment and oxygen via face mask up to 10 L/m. Patients received HFNT (Airvo 2, Fisher & Paykel) at a gas flow of 50 L/min and FIO2 adjusted to maintain SpO(2) >= 92%. Dyspnea, rated by Borg scale, RR, arterial blood gases and mucus production (ranging from 1 to 3) were collected befor…

Pulmonary and Respiratory MedicineMaleAcute exacerbation of chronic obstructive pulmonary diseasemedicine.medical_specialtyExacerbationbronchiectasishumidification03 medical and health sciencesPulmonary Disease Chronic Obstructivebronchiectasi0302 clinical medicineacute respiratory failure bronchiectasis COPD High flow nasal cannula humidification mucus plug sputumRespiratory RateInternal medicineMedicineCannulaHumansCOPDIn patientAcute respiratory failure030212 general & internal medicineProspective StudiesAgedCOPDBronchiectasisacute respiratory failurebusiness.industryOxygen Inhalation TherapysputumCarbon Dioxidemedicine.diseaseSymptom Flare UpHigh flow nasal cannulaMucusDyspnea030228 respiratory systemmucus plugSputumFeasibility StudiesFemalemedicine.symptomBlood Gas AnalysisbusinessHigh flow
researchProduct

Usefulness of Oscillations Added to Mechanical In-Exsufflation in Amyotrophic Lateral Sclerosis.

2019

BACKGROUND: Assisted coughing via mechanical in-exsufflation (MI-E) is a first-line treatment for secretion management in patients with amyotrophic lateral sclerosis (ALS) with unassisted CPF METHODS: We conducted a 12-month, prospective, randomized follow-up study of subjects with ALS for whom assisted coughing techniques were indicated. One group was treated with oscillations in addition to MI-E (MI-E+O), and the other group was treated with conventional MI-E. RESULTS: 29 subjects were included in the MI-E group and 27 subjects were included in the MI-E+O group. Five subjects (8.9%) required invasive techniques for secretion management (3 in the MI-E group and 2 in the MI-E+O group, P = .…

Pulmonary and Respiratory MedicineMaleCritical Care and Intensive Care Medicine03 medical and health sciences0302 clinical medicineTracheostomyBronchoscopymedicineHumansIn patientProspective StudiesAmyotrophic lateral sclerosisRespiratory systemRespiratory Tract InfectionsAgedAged 80 and overbusiness.industryAmyotrophic Lateral SclerosisInsufflationGeneral MedicineOdds ratioMiddle Agedmedicine.disease030228 respiratory systemCoughAnesthesiaFemaleExsufflationbusinessRespiratory InsufficiencyFollow-Up StudiesRespiratory care
researchProduct

Tolerance of Volume Control Noninvasive Ventilation in Subjects With Amyotrophic Lateral Sclerosis.

2015

BACKGROUND: Noninvasive ventilation (NIV) tolerance has been identified as an independent predictor of survival in amyotrophic lateral sclerosis (ALS). Volume control continuous mandatory ventilation (VC-CMV) NIV has been associated with poor tolerance. The aim of this study was to determine the tolerance of subjects with ALS to VC-CMV NIV. METHODS: This was a prospective study involving subjects with ALS who were treated with VC-CMV NIV. Respiratory and functional parameters were recorded when the subjects began ventilatory support. NIV tolerance was evaluated after 3 months. RESULTS: Eighty-seven subjects with ALS were included. After 3 months, 80 subjects (92%) remained tolerant of NIV. …

Pulmonary and Respiratory MedicineMaleNeuromuscular diseaseTime FactorsPeak Expiratory Flow RateCritical Care and Intensive Care MedicineVolume controlContinuous mandatory ventilationForced Expiratory VolumemedicineHumansProspective StudiesRespiratory systemAmyotrophic lateral sclerosisProspective cohort studyAgedNoninvasive Ventilationbusiness.industryAmyotrophic Lateral SclerosisGeneral MedicineMiddle Agedmedicine.diseaseRespiratory failureCoughAnesthesiaNoninvasive ventilationFemalebusinessRespiratory InsufficiencyRespiratory care
researchProduct

A Bayesian cost-effectiveness analysis of a telemedicine-based strategy for the management of sleep apnoea: a multicentre randomised controlled trial

2015

Background Compliance with continuous positive airway pressure (CPAP) therapy is essential in patients with obstructive sleep apnoea (OSA), but adequate control is not always possible. This is clinically important because CPAP can reverse the morbidity and mortality associated with OSA. Telemedicine, with support provided via a web platform and video conferences, could represent a cost-effective alternative to standard care management. Aim To assess the telemedicine impact on treatment compliance, cost-effectiveness and improvement in quality of life (QoL) when compared with traditional face-to-face follow-up. Methods A randomised controlled trial was performed to compare a telemedicine-bas…

Pulmonary and Respiratory MedicineMaleTelemedicinemedicine.medical_specialtyEpidemiologymedicine.medical_treatmentCost-Benefit Analysislaw.inventionIndirect costsClinical trialsQuality of lifeRandomized controlled triallawmedicineHumansContinuous positive airway pressureProspective StudiesDisease management (health)EpidemiologiaTelecommunication in medicineSleep apnea syndromesPrimary health careSleep Apnea ObstructiveContinuous Positive Airway Pressurebusiness.industryDisease ManagementBayes TheoremCost-effectiveness analysisSíndromes d'apnea del sonMiddle AgedTelemedicinenervous system diseasesrespiratory tract diseasesClinical trialAtenció primàriaPhysical therapyQuality of LifePatient ComplianceFemalebusinessSleepFollow-Up StudiesTelecomunicació en medicinaAssaigs clínics
researchProduct